STOCK TITAN

RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

RadNet (NASDAQ: RDNT), a leading provider of outpatient diagnostic imaging services, announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's senior management team, including CEO Dr. Howard Berger, CFO Mark Stolper, and EVP Mital Patel, will present on September 9th, 2025, at 4:50 PM ET at the Sheraton New York Times Square Hotel.

The presentation will be accessible through a simultaneous webcast and will also be archived for future viewing through the provided webcast link.

RadNet (NASDAQ: RDNT), principale fornitore di servizi di diagnostica per immagini ambulatoriale, ha annunciato la propria partecipazione al Morgan Stanley 23rd Annual Global Healthcare Conference. Il team di senior management, tra cui l'amministratore delegato Dr. Howard Berger, il CFO Mark Stolper e l'EVP Mital Patel, presenterà il 9 settembre 2025 alle 16:50 ET presso lo Sheraton New York Times Square Hotel.

La presentazione sarà trasmessa in contemporanea via webcast e sarà archiviata per la visione successiva tramite il link del webcast fornito.

RadNet (NASDAQ: RDNT), un proveedor líder de servicios de diagnóstico por imágenes ambulatorias, anunció su participación en la Morgan Stanley 23rd Annual Global Healthcare Conference. El equipo de alta dirección de la compañía, incluido el CEO Dr. Howard Berger, el CFO Mark Stolper y el EVP Mital Patel, presentará el 9 de septiembre de 2025 a las 4:50 p.m. ET en el Sheraton New York Times Square Hotel.

La presentación será accesible mediante una transmisión simultánea por webcast y también se archivará para su visualización posterior a través del enlace del webcast proporcionado.

RadNet (NASDAQ: RDNT), 외래 진단 영상 서비스의 선도 기업이 Morgan Stanley 23rd Annual Global Healthcare Conference에 참여한다고 발표했습니다. CEO Dr. Howard Berger, CFO Mark Stolper, EVP Mital Patel 등 회사의 고위 경영진이 2025년 9월 9일 오후 4시 50분 ET에 Sheraton New York Times Square Hotel에서 발표합니다.

발표는 동시 웹캐스트로 시청할 수 있으며, 제공된 웹캐스트 링크를 통해 이후에 다시 보실 수 있도록 아카이브됩니다.

RadNet (NASDAQ: RDNT), fournisseur de premier plan de services d'imagerie diagnostique en ambulatoire, a annoncé sa participation à la Morgan Stanley 23rd Annual Global Healthcare Conference. L'équipe de direction, dont le CEO Dr. Howard Berger, le CFO Mark Stolper et l'EVP Mital Patel, présentera le 9 septembre 2025 à 16h50 ET au Sheraton New York Times Square Hotel.

La présentation sera accessible via un webcast simultané et sera également archivée pour une consultation ultérieure via le lien du webcast fourni.

RadNet (NASDAQ: RDNT), ein führender Anbieter von ambulanten radiologischen Diagnosediensten, gab seine Teilnahme an der Morgan Stanley 23rd Annual Global Healthcare Conference bekannt. Das Führungsteam des Unternehmens, darunter CEO Dr. Howard Berger, CFO Mark Stolper und EVP Mital Patel, wird am 9. September 2025 um 16:50 Uhr ET im Sheraton New York Times Square Hotel präsentieren.

Die Präsentation wird über einen gleichzeitigen Webcast zugänglich sein und über den bereitgestellten Webcast-Link für spätere Abrufe archiviert.

Positive
  • None.
Negative
  • None.

LOS ANGELES, Sept. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, and Mital Patel, Executive Vice President of Financial Planning & Analysis and Chief Administrative Officer, will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025 at 04:50 p.m. Eastern Time.

There will be simultaneous and archived webcasts available at https://event.webcasts.com/starthere.jsp?ei=1734817&tp_key=e39843ed51&tp_special=8

Details for RadNet's Presentation:
Date:Tuesday, September 9, 2025
Time:04:50 p.m. Eastern Time
Location:Sheraton New York Times Square Hotel
  

About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 405 owned and/or operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has a total of over 11,000 team members. For more information, visit http://www.radnet.com.

Contact:
RadNet, Inc.
Mark Stolper, Executive Vice President and Chief Financial Officer
310-445-2928


FAQ

When is RadNet (RDNT) presenting at the Morgan Stanley Healthcare Conference 2025?

RadNet will present at the conference on Tuesday, September 9th, 2025 at 4:50 PM Eastern Time at the Sheraton New York Times Square Hotel.

Who will be presenting for RadNet at the Morgan Stanley Healthcare Conference?

The presenting team includes Dr. Howard Berger (CEO), Mark Stolper (CFO), and Mital Patel (EVP of Financial Planning & Analysis and CAO).

How can investors access RadNet's Morgan Stanley conference presentation?

Investors can access the presentation through a live webcast and archived replay available at the provided webcast link.

What is RadNet's main business focus?

RadNet is a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers.
Radnet

NASDAQ:RDNT

RDNT Rankings

RDNT Latest News

RDNT Latest SEC Filings

RDNT Stock Data

5.49B
66.88M
12.73%
94.02%
8.27%
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES